The vote was 20-2 against recommending the drug’s approval for use against fibromyalgia.
See the original post here:
FBI Agent, 19 Others Vote Against Jazz Pharma’s Drug For Fibromyalgia
In the meantime, regional Medicare carriers can decide whether or not to cover the drug.
Originally posted here:
Medicare to Take a Year For Provenge Coverage Decision
Summer is here, and the ability to hide underneath layers of cloths is gone.
Continued here:
Prescription Weight Loss Options
By 2016, the drug’s annual sales will haveclimbed to $10.1 billion, putting it ahead of Roche’s cancer drug Avastin (with $8.9 billion in sales), predicts EvaluatePharma, a London-based research firm.
See the article here:
Prediction: Lipitor to Cede the ‘Best-Selling’ Crown to Humira
The FDA posted documents today saying the effectiveness of Forest Laboratories’ experimental lung drug Daxas was “quite modest” while expressing concern about side effects seen in clinical trials. In particular, the FDA staff cited three suicides and two suicide attempts among patients using the drug who were studied.
Follow this link:
Suicide Risk May Not Slow Approval of Forest’s Experimental Lung Drug
“In evaluating an anticoagulant,” says heart researcher Michael Ezekowitz, “it’s all about getting the dose right.” That’s the next big challenge for Merck and its partner Portola as they prepare to advance the closely held South San Francisco biotech’s drug betrixaban into a large-scale clinical trial in the burgeoning race to develop a replacement for the heart drug warfarin.
See the rest here:
Merck and Portola: Finding a Blood Thinner’s Sweet Spot
We came across these interesting promotional materials (click the image to enlarge) for Viagra today, so we thought we’d share them. Even though the party blowers mark Viagra’s 11th birthday, by our calculations the drug turns 12 on March 27, 2010 — the anniversary of its FDA approval.
Patients concerned about side effects associated with aspirin, particularly the risk of gastrointestinal problems such as ulcers, often try taking versions of the drug that are coated with enteric.
See the original post here:
Confusion Over Whether Coated Aspirin Can Protect Your Stomach
Last we heard of Fablyn, an experimental bone drug for the treatment of postmenopausal women, U.S. regulators were holding off on approval after FDA staff and outside reviewers raised concerns and Pfizer, the pill’s maker, was shopping it around to other companies.
Read the original post:
Pfizer Experimental Bone Drug Shows Mixed Results In Study
Doctors are narrowing their recommendation on who should take daily aspirin for heart health, based largely on concerns about the drug’s side effects, which can include bleeding ulcers. See here for more about that
Go here to see the original:
Aspirin Blocking Blood Clots: For Some, It Doesn’t Work
